|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-04-2005
NEW YORK (Reuters Health) - Erectile dysfunction is sometimes more than just an issue that negatively impacts a man's quality of life -- it can also be an early sign of heart or blood vessel problems, according to experts.
LOS ANGELES (Reuters) - U.S. regulators approved the first generic rival to Johnson & Johnson's Duragesic pain relief skin patch, the U.S. Food and Drug Administration said on Friday.
NEW YORK (Reuters Health) - Injections of the wrinkle-banisher Botox may help soothe the involuntary muscle contractions that plague some professional musicians, according to a new study.
NEW YORK (Reuters Health) - Elderly women with invasive cervical carcinoma are less likely to receive aggressive treatment than younger patients, and are more likely to die from the disease, a new study shows.
NEW YORK (Reuters Health) - Cooling the head with a special cap may help reduce brain damage in infants with neonatal encephalopathy, a serious neurologic condition that occurs in the first days of life, new research shows. This treatment seems to work for most infants, provided their condition is not too severe.
NEW YORK (Reuters Health) - Even with new, more objective criteria, women are still less likely than men to have their heart condition accurately diagnosed as a heart attack, researchers report.
NEW YORK (Reuters Health) - In the short term, the risk of nonvertebral fracture is not increased in older adults with asthma or chronic obstructive pulmonary disease (COPD) who use inhaled corticosteroids (ICS), a study shows.
LONDON (Reuters) - Britain moved on Friday to impose tougher regulations on the booming cosmetic surgery industry as concerns grow that people seeking beauty can end up disfigured by rogue practitioners.
NEW YORK (Reuters) - Merck and Co. MRK.N suffered a double blow on Friday when a court ruled that the patent on its second-biggest drug will lapse a decade earlier than expected and U.S. regulators elevated their probe of its withdrawn Vioxx arthritis drug into a formal investigation.
NEW YORK (Reuters Health) - In people with diabetes and heart failure, treatment with the beta-blocker metoprolol CR/XL (controlled release/extended release) safely reduces the risk of hospitalization and death, research shows.
|
|
